Sunday, June 23, 2013

More Fallout From Myriad

The following is an email exchange between myself and and Dr. Roger Klein.
Dr Klein, MD JD FASC, is associated with the Association for Molecular Pathology, the lead plaintiff in the Myriad gene patenting case decided June 13, 2024.  The exchange took place on Linkin and Outlook email.  To read the post scroll down to the bottom of the post and up.


We were very pleased with it.


On 06/22/13 3:12 PM, Arthur Gershman wrote:
What is your opinion of the Myriad decision?

On 07/24/12 5:37 AM, Arthur Gershman wrote:
Matthew Dowd, of Wiley Rein.

For details please visit my nascent blog:

The brief is also on the blog.

On 07/24/12 5:21 AM, Roger D. Klein MD, JD, FCAP wrote:
I was there as well. I haven't yet had an opportunity to read Watson's brief. Who is representing him?


No comments:

Post a Comment